Your browser doesn't support javascript.
loading
Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study.
Tikk, Kaja; Sookthai, Disorn; Fortner, Renée T; Johnson, Theron; Rinaldi, Sabina; Romieu, Isabelle; Tjønneland, Anne; Olsen, Anja; Overvad, Kim; Clavel-Chapelon, Françoise; Baglietto, Laura; Boeing, Heiner; Trichopoulou, Antonia; Lagiou, Pagona; Trichopoulos, Dimitrios; Masala, Giovanna; Krogh, Vittorio; Tumino, Rosario; Ricceri, Fulvio; Mattiello, Amalia; Agudo, Antonio; Menéndez, Virginia; Sánchez, María-José; Amiano, Pilar; Chirlaque, Maria-Dolores; Barricarte, Aurelio; Bueno-de-Mesquita, H Bas; Monninkhof, Evelyn M; Onland-Moret, N Charlotte; Andresson, Anne; Sund, Malin; Weiderpass, Elisabete; Khaw, Kay-Tee; Key, Timothy J; Travis, Ruth C; Merritt, Melissa A; Riboli, Elio; Dossus, Laure; Kaaks, Rudolf.
Afiliación
  • Tikk K; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. k.tikk@dkfz.de.
  • Sookthai D; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ) Heidelberg, Im Neuenheimer Feld 581, D-69120, Heidelberg, Germany. k.tikk@dkfz.de.
  • Fortner RT; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. d.sookthai@dkfz-heidelberg.de.
  • Johnson T; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. r.fortner@dkfz-heidelberg.de.
  • Rinaldi S; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. t.johnson@dkfz-heidelberg.de.
  • Romieu I; Section of Nutrition and Metabolism, International Agency for Research on Cancer (IARC), Lyon, France. RinaldiS@iarc.fr.
  • Tjønneland A; Section of Nutrition and Metabolism, International Agency for Research on Cancer (IARC), Lyon, France. romieui@iarc.fr.
  • Olsen A; Danish Cancer Society Research Center, Copenhagen, Denmark. annet@cancer.dk.
  • Overvad K; Danish Cancer Society Research Center, Copenhagen, Denmark. anja@cancer.dk.
  • Clavel-Chapelon F; Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark. ko@soci.au.dk.
  • Baglietto L; INSERM, Centre for Research in Epidemiology and Population Health [CESP], U1018, Nutrition, Hormones and Women's Health team, F-94805, Villejuif, France. francoise.clavel@igr.fr.
  • Boeing H; University Paris Sud, UMRS 1018, F-94805, Villejuif, France. francoise.clavel@igr.fr.
  • Trichopoulou A; IGR, F-94805, Villejuif, France. francoise.clavel@igr.fr.
  • Lagiou P; Cancer Epidemiology Centre, Cancer Council Victoria, 3053, Melbourne, Australia. Laura.Baglietto@cancervic.org.au.
  • Trichopoulos D; Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, 3010, Melbourne, Australia. Laura.Baglietto@cancervic.org.au.
  • Masala G; Department of Epidemiology, German Institute of Human Nutrition (DIfE) Potsdam-Rehbrücke, Nuthetal, Germany. boeing@dife.de.
  • Krogh V; Hellenic Health Foundation, 13 Kaisareias Street, GR-115 27, Athens, Greece. atrichopoulou@hhf-greece.gr.
  • Tumino R; Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, 75 M. Asias Street, Goudi, GR-115 27, Athens, Greece. atrichopoulou@hhf-greece.gr.
  • Ricceri F; Bureau of Epidemiologic Research, Academy of Athens, 23 Alexandroupoleos Street, Athens, GR-115 27, Greece. atrichopoulou@hhf-greece.gr.
  • Mattiello A; Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, 75 M. Asias Street, Goudi, GR-115 27, Athens, Greece. pdlagiou@med.uoa.gr.
  • Agudo A; Bureau of Epidemiologic Research, Academy of Athens, 23 Alexandroupoleos Street, Athens, GR-115 27, Greece. pdlagiou@med.uoa.gr.
  • Menéndez V; Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, USA. pdlagiou@med.uoa.gr.
  • Sánchez MJ; Hellenic Health Foundation, 13 Kaisareias Street, GR-115 27, Athens, Greece. dtrichop@hsph.harvard.edu.
  • Amiano P; Bureau of Epidemiologic Research, Academy of Athens, 23 Alexandroupoleos Street, Athens, GR-115 27, Greece. dtrichop@hsph.harvard.edu.
  • Chirlaque MD; Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, USA. dtrichop@hsph.harvard.edu.
  • Barricarte A; Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy. g.masala@ispo.toscana.it.
  • Bueno-de-Mesquita HB; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milano, Italy. vittorio.krogh@istitutotumori.mi.it.
  • Monninkhof EM; Cancer Registry and Histopathology Unit, "Civic - M.P.Arezzo" Hospital ASP, Ragusa, Italy. rtumino@tin.it.
  • Onland-Moret NC; Unit of Cancer Epidemiology, AO Citta' della Salute e della Scienza, University of Turin, Torino, Italy. fulvio.ricceri@gmail.com.
  • Andresson A; Center for Cancer Prevention (CPO), Via Santena 7, 10126, Torino, Italy. fulvio.ricceri@gmail.com.
  • Sund M; Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy. amattiel@unina.it.
  • Weiderpass E; Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology-ICO, IDIBELL, L'Hospitalet de Llobregat, Barcelona, 08908, Spain. a.agudo@iconcologia.net.
  • Khaw KT; Public Health Directorate, Asturias, Spain. virginia.menendezgarcia@asturias.org.
  • Key TJ; Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitario de Granada (Granada.ibs), Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain. mariajose.sanchez.easp@juntadeandalucia.es.
  • Travis RC; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiología y Salud Pública (CIBERESP)), Madrid, Spain. mariajose.sanchez.easp@juntadeandalucia.es.
  • Merritt MA; Public Health Division of Gipuzkoa, BioDonostia Reserach Institute, San Sebastian, Spain. epicss-san@ej-gv.es.
  • Riboli E; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiología y Salud Pública (CIBERESP)), Madrid, Spain. epicss-san@ej-gv.es.
  • Dossus L; Department of Epidemiology, Murcia Regional Health Authority, Murcia, Spain. mdolores.chirlaque@carm.es.
  • Kaaks R; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiología y Salud Pública (CIBERESP)), Madrid, Spain. mdolores.chirlaque@carm.es.
Breast Cancer Res ; 17: 49, 2015 Mar 31.
Article en En | MEDLINE | ID: mdl-25887963
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Prolactina / Neoplasias de la Mama / Carcinoma in Situ Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Prolactina / Neoplasias de la Mama / Carcinoma in Situ Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Breast Cancer Res Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Alemania